A study of a new tablet in healthy adults
Part of Digestive system clinical trials.
This trial tests a new tablet medication (called QLS1510) for the first time in people. It is for healthy volunteers to check how the drug is processed by the body and whether it is safe, which helps decide if it can be tested in patients later.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You need to be in good general health with no major medical conditions.
- You must weigh at least 50 kg (110 lbs) if you are a man, or 45 kg (99 lbs) if you are a woman, and have a body mass index (BMI) between 18 and 26.
- You and your partner must agree to use highly effective birth control and not donate sperm or eggs during the study.
- You must not have taken part in another clinical trial or received a live vaccine within the last 6 weeks.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new investigational drug called PVT401 in healthy people. It is a first-in-human study to see how the drug is handled by the body and to check for any side effects.
This study checks if taking the experimental drug with food changes how it works in the body. It helps decide the best way to take the drug in future studies.
This trial tests a new drug called QLS2312, given as an injection, to see if it is safe and how the body handles it. It is an early study in healthy volunteers that helps decide if the drug can be studied in people with certain conditions.
This study tests a new investigational drug (called LMT503) for the first time in humans, in healthy volunteers. It is a phase 1 trial that will look at how the body processes the drug and its safety, including how it behaves in the blood. The trial involves taking the drug once (single dose) or multiple times over several days, with close monitoring by the research team.
This is an early-stage safety study testing a new experimental tablet called BDHK-2009 in healthy volunteers with no major illnesses. Researchers want to make sure the drug is safe and well-tolerated before testing it in people with medical conditions.
This study tests a new investigational tablet in healthy adults to see how the body handles it and if it's safe. The results will help guide future research.
Hear when a new Inflammatory Bowel Disease (IBD) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.